慢性肾脏病中的血小板功能:系统综述与荟萃分析
该系统综述与荟萃分析纳入73项研究评估CKD对血小板功能的整体影响,其中11项关于离体血小板聚集的研究进入荟萃分析。结果显示CKD患者出血时间多延长、血小板黏附主要降低,胶原刺激下最大血小板聚集显著降低,但相当数量研究报告血小板功能未变或增强。
要点
- CKD患者出血时间多延长,血小板黏附主要降低。
- 荟萃分析显示胶原刺激下CKD患者最大血小板聚集显著降低。
- 部分研究报告CKD患者血小板功能未变或增强,结果不一致。
核心结论
- 多数研究报告CKD患者血小板功能受损,但相当数量研究报告未变或增强。
研究设计与样本
- 系统综述与荟萃分析,共纳入73项研究评估CKD对血小板功能的影响,其中11项关于离体血小板聚集的研究进入荟萃分析。
- 另进行广泛文献检索评估单个尿毒症毒素对血小板功能的直接效应。
主要发现
- CKD患者出血时间多延长,血小板黏附主要降低。
- 荟萃分析显示胶原刺激下CKD患者最大血小板聚集显著降低。
- 离体分析中尿毒症毒素对血小板功能显示刺激和抑制双重效应。
- 动物模型中测试的12种尿毒症毒素中有8种主要诱导促血栓效应。
局限性
- CKD中血小板异常的研究结果不一致。
- 仅相对少数尿毒症毒素被评估对血小板的离体直接效应,且方法和结果各异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with CKD are at high risk for thrombotic and hemorrhagic complications. Abnormalities in platelet function are central to these complications, but reports on platelet function in relation to CKD are conflicting, and vary from decreased platelet reactivity to normal or increased platelet responsiveness. The direct effects of uremic toxins on platelet function have been described, with variable findings. METHODS: To help clarify how CKD affects platelet function, we conducted a systematic review and meta-analysis of platelet activity in CKD, with a focus on nondialysis-induced effects. We also performed an extensive literature search for the effects of individual uremic toxins on platelet function. RESULTS: We included 73 studies in the systematic review to assess CKD's overall effect on platelet function in patients; 11 of them described CKD's effect on ex vivo platelet aggregation and were included in the meta-analysis. Although findings on platelet abnormalities in CKD are inconsistent, bleeding time was mostly prolonged and platelet adhesion mainly reduced. Also, the meta-analysis revealed maximal platelet aggregation was significantly reduced in patients with CKD upon collagen stimulation. We also found that relatively few uremic toxins have been examined for direct effects on platelets ex vivo; ex vivo analyses had varying methods and results, revealing both platelet-stimulatory and inhibitory effects. However, eight of the 12 uremic toxins tested in animal models mostly induced prothrombotic effects. CONCLUSIONS: Overall, most studies report impaired function of platelets from patients with CKD. Still, a substantial number of studies find platelet function to be unchanged or even enhanced. Further investigation of platelet reactivity in CKD, especially during different CKD stages, is warranted.
引用
- Baaten CCFMJ, Sternkopf M, Henning T, et al. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol. 2021. PMID: 33941607. doi:10.1681/ASN.2020101440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。